Publication | Closed Access

Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine

BiosynthesisFission YeastBiochemistryBiotechnological SynthesisMedicineSecondary MetaboliteNatural Product BiosynthesisPathway EngineeringDesigner DrugPharmacologyDrug Discovery